Afuco™ Anti-Human C2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-C2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a monoclonal antibody which bound to C2a and blocked its ability to activate complement, the use of such inhibitor molecules to block complement activation via the classical pathway and the lectin pathway, treatment of diseases associated with excessive complement activation, and the diagnostic determination of the amount of C2a present in a biological sample.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-077CL |
| Pricing | Inquiry |
| Host | Human |
| Target | C2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4 °C, -20°C if preferred |